Melanoma Investigators Strive to Overcome PD-1 Inhibitor Resistance
May 17th 2019Investigators across the globe have expended considerable effort attempting to identify mechanisms of response and resistance to ICIs. The general conclusion is that each patient’s response to immunotherapy is likely complex and highly individualized.